Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Garver

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Psychiatry|May 16, 2000
Review of quetiapine side effectsD L Garver
Schizophrenia Bulletin|January 1, 1987
Methodological issues facing the interpretation of high-risk studies: biological heterogeneityD L Garver
Harvard Review of Psychiatry|March 1, 1997
The etiologic heterogeneity of schizophreniaD L Garver
Endocrinology and Metabolism Clinics of North America|March 1, 1988
Neuroendocrine findings in the schizophreniasD L Garver
Comprehensive Therapy|December 1, 1984
A psychobiologic perspective in treating psychiatric disordersD L Garver
Neurologic Clinics|February 1, 1988
Neuroendocrine findings in the schizophreniasD L Garver
The Ohio State Medical Journal|February 1, 1984
Recent developments in the treatment of psychiatric disordersD L Garver
Psychopharmacology Series|January 1, 1989
Neuroleptic drug levels in erythrocytes and in plasma: implications for therapeutic drug monitoringD L Garver
Journal of Clinical Psychopharmacology|August 1, 1989
Neuroleptic drug levels and antipsychotic effects: a difficult correlation; potential advantage of free (or derivative) versus total plasma levelsD L Garver
Psychiatry Research|December 1, 1988
Psychosis, lithium-induced antipsychotic response, and seasonalityD L Garver, L J Hutchinson
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Psychiatry|May 16, 2000
Review of quetiapine side effectsD L Garver
Schizophrenia Bulletin|January 1, 1987
Methodological issues facing the interpretation of high-risk studies: biological heterogeneityD L Garver
Harvard Review of Psychiatry|March 1, 1997
The etiologic heterogeneity of schizophreniaD L Garver
Endocrinology and Metabolism Clinics of North America|March 1, 1988
Neuroendocrine findings in the schizophreniasD L Garver
Comprehensive Therapy|December 1, 1984
A psychobiologic perspective in treating psychiatric disordersD L Garver
Neurologic Clinics|February 1, 1988
Neuroendocrine findings in the schizophreniasD L Garver
The Ohio State Medical Journal|February 1, 1984
Recent developments in the treatment of psychiatric disordersD L Garver
Psychopharmacology Series|January 1, 1989
Neuroleptic drug levels in erythrocytes and in plasma: implications for therapeutic drug monitoringD L Garver
Journal of Clinical Psychopharmacology|August 1, 1989
Neuroleptic drug levels and antipsychotic effects: a difficult correlation; potential advantage of free (or derivative) versus total plasma levelsD L Garver
Psychiatry Research|December 1, 1988
Psychosis, lithium-induced antipsychotic response, and seasonalityD L Garver, L J Hutchinson
Pageof 10